M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine. (Q55184907)
Jump to navigation
Jump to search
scientific article published on 14 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine. |
scientific article published on 14 February 2018 |
Statements
1 reference
M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine. (English)
1 reference
Jeffrey Schlom
1 reference
Sofia R Gameiro
1 reference
Karin M Knudson
1 reference
Kristin C Hicks
1 reference
Xiaoling Luo
1 reference
Jin-Qiu Chen
1 reference
14 February 2018
1 reference
1 reference
7
1 reference
5
1 reference
e1426519
1 reference
1 reference
Identifiers
1 reference
1 reference